Noninfectious Posterior Segment Uveitis
📧 Sign up to get email alerts when something new happens for Noninfectious Posterior Segment Uveitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-10-21FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OZURDEX (dexamethasone) by Allergan, Inc.
-
FDA approval · 2018-10-12FDA Approved: YUTIQ — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved YUTIQ (fluocinolone acetonide) through ANI Pharmaceuticals' original application for the treatment of noninfectious posterior s…
-
FDA approval · 2012-02-24FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OZURDEX (dexamethasone) from Allergan, Inc.
-
FDA approval ·FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for OZURDEX (dexamethasone) by Allergan, Inc.